SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) (AYTU) — Apr 29, 2016

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)
Date: April 29, 2016 · CIK: 0001385818 · Accession: 0001144204-16-097522

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-210144

Date
April 29, 2016
Author
JOSEPH GUNNAR & CO., LLC
Form
CORRESP
Company
AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)

Letter

JOSEPH GUNNAR & CO., LLC

30 Broad Street, 11th Fl

New York, NY 10004

April 29, 2016

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re: Aytu Bioscience, Inc. (the “Company”)

File No. 333-210144

Registration Statement on Form S-1

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), we, the representative of the several underwriters (the “Representative”), hereby join in the request of the Company that the effective time of the above-referenced Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern Time on Monday, May 2, 2016, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, please be advised that during the period from April 25, 2016 to the date of this letter, we, acting on behalf of the several underwriters, distributed as many copies of the Preliminary Prospectuses, dated April 25, 2016 as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

Very truly yours,
JOSEPH GUNNAR & CO., LLC

Show Raw Text
CORRESP
1
filename1.htm

JOSEPH GUNNAR & CO., LLC

30 Broad Street, 11th Fl

New York, NY 10004

 April 29, 2016

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Aytu Bioscience, Inc. (the “Company”)

    File No. 333-210144

    Registration Statement on Form S-1

Ladies and Gentlemen:

Pursuant to Rule 461
of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended
(the “Securities Act”), we, the representative of the several underwriters (the “Representative”), hereby
join in the request of the Company that the effective time of the above-referenced Registration Statement be accelerated so that
it will be declared effective at 5:00 p.m. Eastern Time on Monday, May 2, 2016, or as soon thereafter as practicable.

Pursuant to Rule 460
under the Securities Act, please be advised that during the period from April 25, 2016 to the date of this letter, we, acting on
behalf of the several underwriters, distributed as many copies of the Preliminary Prospectuses, dated April 25, 2016 as appears
to be reasonable to secure adequate distribution of the Preliminary Prospectus.

    Very truly yours,

    JOSEPH GUNNAR & CO., LLC

    By:  /s/ Eric Lord

    Name: Eric Lord

    Title:
Head of Investment

         Banking/Underwritings